Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Peter Tak currently holds 113,321 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Peter Tak has been a net seller of CADL stock. They have purchased $230.0K and sold $3.4M worth of shares.
Paul Peter Tak's most recent insider trade was on Sep 11, 2026, when they sold 59,379 shares at $10.46 per share.
Paul Peter Tak serves as Executive at Candel Therapeutics, Inc. (CADL). They have executed 13 insider transactions totaling $3.7M over their tenure at the company.
Paul Peter Tak holds the position of Executive at Candel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Paul Peter Tak has shown a selling trading pattern, with $230.0K in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Peter Tak was on Sep 10, 2026, when they sold $2.5M worth of CADL shares. This transaction involved 220,866 shares at $11.50 per share.
Paul Peter Tak currently owns 113,321 shares of Candel Therapeutics, Inc. (CADL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Peter Tak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Peter Tak has 13 Form 4 filings on record as an insider at Candel Therapeutics, Inc..
Set alerts for Paul Peter Tak and 40,000+ other insiders.